Man Group
SURF

Man Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Man Group’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-38,864
Closed -$31.9K – 2308
2022
Q4 		$31.9K Buy
38,864
+25,464
+190% +$25.1K ﹤0.01% 1969
2022
Q3 		$14K Buy
+13,400
New +$21.4K ﹤0.01% 1959
2021
Q2 		– Sell
-27,222
Closed -$212K – 2135
2021
Q1 		$212K Sell
27,222
-93,102
-77% -$931K ﹤0.01% 1742
2020
Q4 		$1.11M Buy
120,324
+88,624
+280% +$770K ﹤0.01% 1386
2020
Q3 		$219K Buy
+31,700
New +$192K ﹤0.01% 1688
2019
Q2 		– Sell
-56,987
Closed -$272K – 2044
2019
Q1 		$272K Sell
56,987
-79,208
-58% -$390K ﹤0.01% 1825
2018
Q4 		$577K Hold
136,195
– – ﹤0.01% 1599
2018
Q3 		$1.49M Buy
136,195
+61,195
+82% +$717K 0.01% 1515
2018
Q2 		$1.22M Buy
+75,000
New +$1.09M 0.01% 1546

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Man Group's SURF Position: Q1 2023 in Review

Man Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2023, closing a stake of 38,864 shares — an estimated $31.9K sold.

Man Group first reported a position in SURF in Q2 2018 and held it in 9 quarters. The position peaked at $1.49M in Q3 2018. 71 funds tracked by Wall St. Rank hold SURF as of Q1 2023.

  • Man Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Man Group sold 38,864 Surface Oncology, Inc. Common Stock shares in Q1 2023, an estimated $31.9K.
  • Man Group first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
  • Man Group's Surface Oncology, Inc. Common Stock position peaked at $1.49M in Q3 2018.
  • 71 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.